Sciatic nerve regeneration by transplantation of in vitro differentiated nucleus pulposus progenitor cells. (June 2017)

• Record Type: Journal Article
• Authors: Ishii, Takayuki; Sakai, Daisuke; Schol, Jordy; Nakai, Tomoko; Suyama, Kaori; Watanabe, Masahiko
• Is Part Of: Regenerative medicine. Volume 12:Number 4(2017)
• Page Start: 365
• Page End: 376
• Publication Date: 2017-06
• Subjects: cell therapy -- neurology -- neuroregeneration -- nucleus pulposus -- Schwann cells; Cellular therapy -- Periodicals; Stem cells -- Transplantation -- Periodicals; Degeneration (Pathology) -- Treatment -- Periodicals; Regeneration (Biology) -- Periodicals; 611.018
• DOI: 10.2217/rme-2016-0168
• Languages: English
• ISSNs: 1746-0751

Abstract

Aim: To assess the applicability of mouse intervertebral disc-derived nucleus pulposus (NP) progenitor cells as a cell source for sciatic nerve regeneration.Materials & methods: P0-Cre/Floxed-EGFP-transgenic mouse-derived NP progenitor cells were differentiated to Schwann-like cells in conventional induction medium. Schwann-like cells were subsequently transplanted into a mouse model of sciatic nerve transection, and nerve regeneration assessed by immunohistochemistry, electron microscopy and functional walking track analysis and heat stimulus reflex.Results & conclusion: NP progenitor cells differentiated into Schwann-like cells. Transplantation of these cells promoted myelinated axon formation, morphology restoration and nerve function improvement. NP progenitor cells have the capacity to differentiate into neuronal cells and are candidates for peripheral nerve regeneration therapy.